Clinical Trial Update: Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating interactions between HIV pre-exposure prophylaxis (PrEP) and gender-affirming hormone therapy in transgender women has completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• ESTRADIOL (Estradiol)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Johns Hopkins University | Conditions: HIV, Prophylaxis | Phase 1 | Status: COMPLETED | Results posted: 2026-04-03